West Pharmaceutical Services, Inc. WST

370.44 (3.16) (0.85%) as of 25 Sep
Market cap
$26.3B
P/E
47.1×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

West Pharmaceutical Services, Inc. (WST) Operating margin

West Pharmaceutical Services, Inc.'s operating margin over the twelve months to 30 June 2026 was 20.5%, up 1.4 percentage points from fiscal 2025 (19.0%). Over the past ten years it has ranged from 9.19% (fiscal 2015) to 26.6% (fiscal 2021); the current reading is higher than 64% of that period. That is above the Medical Instruments & Supplies industry median of 1.64% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Annual

Period Operating margin Change (points)
FY2025 19.0% (0.67)
FY2024 19.7% (3.22)
FY2023 22.9% (2.51)
FY2022 25.4% (1.14)
FY2021 26.6% 7.62
FY2020 19.0% 2.83
FY2019 16.1% 2.13
FY2018 14.0% (0.13)
FY2017 14.1% 1.19
FY2016 12.9% 3.74

Quarterly

Period Operating margin Change (points)
Jun 2026 20.5% (0.43)
Mar 2026 21.0% 1.51
Dec 2025 19.5% (1.38)
Sep 2025 20.8% 0.78
42 more quarters

Against its own ten years

Low 9.19% High 26.6%
Ten-year median 19.0%
Current reading's percentile 64

Operating margin against peers

Company Operating margin
RMD ResMed Inc. compare 33.4%
MDLN Medline Inc. compare 31.1%
SOLV Solventum Corporation compare 25.0%
WST West Pharmaceutical Services, Inc. 20.5%
COO The Cooper Companies, Inc. compare 12.8%
BDX Becton, Dickinson and Company compare 10.3%
ALC Alcon compare 8.73%
RGEN Repligen Corporation compare 8.23%
BAX Baxter International Inc. compare −2.39%
Medical Instruments & Supplies industry median 1.64%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on WST